(PharmaNewsWire.Com, May 30, 2020 ) The growing prevalence of neurological diseases, efforts to develop the application base for neuromodulation, and the benefits of neuroendoscopic surgeries over conventional brain surgeries are driving the growth of the neurosurgery devices market.
The neurosurgery devices market is expected to grow from USD 7.3 billion in 2019 to USD 13.5 billion in 2024, at a CAGR of 13.0%.
By product, the neuromodulation devices segment is expected to grow at the highest CAGR during the forecast period.
On the basis of product, the neurosurgery instruments market is segmented into neuromodulation devices and neuroendoscopy devices. The neuromodulation devices segment is projected to register the highest growth during the forecast period. The rising prevalence of neurological disorders and the increasing number of brain surgeries are driving the growth of the neuromodulation devices market.
Parkinson's disease segment accounted for the largest share of the deep brain stimulation applications market in 2018. The large share of this segment can be attributed to the rising incidence of Parkinson’s, along with the growing number of researches conducted in this field.
North America accounted for the largest share of the market. Factors such as the high prevalence of neurological disorders, large number of neurosurgical procedures performed, and the presence of a favorable reimbursement structure are supporting the growth of the North American neurosurgery devices market. However, the Asia Pacific market is projected to register the highest CAGR of 14.8% during the forecast period, primarily due to the growing geriatric population in Japan and China and healthcare reforms and government initiatives & investments in several APAC countries.
Major players in this neurosurgery instruments market include B. Braun Melsungen (Germany), Medtronic (US), Boston Scientific Corporation (US), Nevro Corporation (US), KARL STORZ (Germany), Abbott (US), Ackermann Instrumente (Germany), Hawk (China), Machida Endoscope (Japan), and adeor Medical (Germany).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
